These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34596795)

  • 1. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A
    Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.
    Medle B; Sjödahl G; Eriksson P; Liedberg F; Höglund M; Bernardo C
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
    Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
    Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid in colorectal cancer: progress and challenges.
    Ji DB; Wu AW
    Chin Med J (Engl); 2020 Aug; 133(16):1971-1977. PubMed ID: 32826461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review.
    DeHaan RK; Sarvestani SK; Huang EH
    Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective experimental treatment of colorectal cancer patients based on organoid drug responses.
    Ooft SN; Weeber F; Schipper L; Dijkstra KK; McLean CM; Kaing S; van de Haar J; Prevoo W; van Werkhoven E; Snaebjornsson P; Hoes LR; Chalabi M; van der Velden D; van Leerdam M; Boot H; Grootscholten C; Huitema ADR; Bloemendal HJ; Cuppen E; Voest EE
    ESMO Open; 2021 Jun; 6(3):100103. PubMed ID: 33887686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organoids as a milestone on the way to personalized treatment of urothelial carcinoma: a systematic review].
    Melzer MK; Zehe V; Zengerling F; Wezel F; Günes C; Maisch P; Bolenz C
    Urologie; 2022 Jul; 61(7):745-752. PubMed ID: 35925247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling rectal cancer to advance neoadjuvant precision therapy.
    Janakiraman H; Zhu Y; Becker SA; Wang C; Cross A; Curl E; Lewin D; Hoffman BJ; Warren GW; Hill EG; Timmers C; Findlay VJ; Camp ER
    Int J Cancer; 2020 Sep; 147(5):1405-1418. PubMed ID: 31989583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.
    Wang HM; Zhang CY; Peng KC; Chen ZX; Su JW; Li YF; Li WF; Gao QY; Zhang SL; Chen YQ; Zhou Q; Xu C; Xu CR; Wang Z; Su J; Yan HH; Zhang XC; Chen HJ; Wu YL; Yang JJ
    Cell Rep Med; 2023 Feb; 4(2):100911. PubMed ID: 36657446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor organoid model of colorectal cancer (Review).
    Yang C; Xiao W; Wang R; Hu Y; Yi K; Sun X; Wang G; Xu X
    Oncol Lett; 2023 Aug; 26(2):328. PubMed ID: 37415635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
    Roy P; Canet-Jourdan C; Annereau M; Zajac O; Gelli M; Broutin S; Mercier L; Paci A; Lemare F; Ducreux M; Elias D; Malka D; Boige V; Goéré D; Jaulin F
    Int J Pharm; 2017 Oct; 531(1):143-152. PubMed ID: 28803938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
    Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
    J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Organoids: The Era of Personalized Medicine.
    Rassomakhina NV; Ryazanova AY; Likhov AR; Bruskin SA; Maloshenok LG; Zherdeva VV
    Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S127-S147. PubMed ID: 38621748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.